91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Global Active Pharmaceutical Ingredients (API) Market Report 2018-2029

Global Active Pharmaceutical Ingredients (API) Market Report 2018-2029

Publication ID: 
HJR06230320
Publication Date: 
June 29, 2023
Pages: 
146
Publisher: 
HJResearch
Countries: 
Global [1]
USD 3,200.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Specialty Chemicals [2]
Manufacturing (Chemicals) [3]
Chemicals [4]
Description: 

The Active Pharmaceutical Ingredients (API) industry is an essential component of the pharmaceutical industry. The API refers to the biologically active components in a pharmaceutical product that are responsible for its therapeutic effects. It is the primary ingredient used in the manufacture of pharmaceutical drugs.

APIs are used in a wide range of applications, including CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology, and others. The use of APIs is critical as it allows for the creation of safe and effective medicines that can treat various health conditions.

The global Active Pharmaceutical Ingredients (API) market size is expected to reach US$179706 million by 2022, with a compound annual growth rate of 7.5%. This growth is driven by several factors, including the increasing prevalence of chronic diseases, aging populations, and rising healthcare expenditure.

The CNS segment is the largest consumer of APIs, accounting for over 25% of the total market share. The increasing incidence of neurological disorders such as Alzheimer’s disease and Parkinson’s disease is driving demand in this segment. The cardiovascular segment is the second-largest consumer of APIs, followed by oncology and diabetes.

The major global manufacturers in the API industry include Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer, Huahai Pharmaceutical, Hisun Pharmaceutical, Sun Pharmaceutical Industries, Zhejiang Medicine, Dr. Reddy’s Laboratories, Zhejiang NHU, Bayer, NCPC, AbbVie, Shandong Xinhua Pharmaceutical, Northeast Pharm, Harbin Pharmaceutical, and LKPC. These companies are investing heavily in research and development to improve the quality and efficiency of their products, as well as expanding their product lines to meet the evolving needs of their customers.

Looking ahead, the prospects for the API industry are positive, driven by the increasing demand for safe and effective medicines. The rising incidence of chronic diseases and the development of new therapies are expected to provide significant growth opportunities for the industry.

In conclusion, the API industry is a critical component of the pharmaceutical industry, providing the biologically active components that form the basis for safe and effective medicines. With significant growth projections, a diverse range of applications, and established global manufacturers, the API industry is poised for continued success. Manufacturers in this industry should focus on innovation and expansion to capitalize on growth opportunities and stay ahead of competitors.

The SWOT analysis of the Active Pharmaceutical Ingredients (API) industry is as follows:

Strengths:
Strong demand for APIs due to the increasing prevalence of chronic diseases and aging populations.
High barriers to entry due to stringent quality and regulatory standards.
Established global manufacturers with strong brand recognition and extensive experience in research and development.
Technological advancements in manufacturing processes, leading to increased efficiency and cost-effectiveness.

Weaknesses:
Dependence on patent protection for profitability, with product lines becoming obsolete once patents expire.
High fixed costs associated with research and development, manufacturing, and regulatory compliance.
Fragmented market with intense competition among manufacturers.
Limited flexibility in modifying production to accommodate changes in demand or supply chain disruptions.

Opportunities:
Expansion into emerging markets with high growth potential, such as Asia-Pacific and Latin America.
Development of new generics and biosimilars to replace branded products.
Demand for personalized medicine and targeted therapies.
Use of technology to improve manufacturing processes, such as continuous manufacturing and digitalization.

Threats:
Intense competition from alternative suppliers and substitute products, such as contract manufacturing organizations and generic drug manufacturers.
Regulatory challenges and increasing scrutiny on quality standards.
Price pressures from healthcare payers and regulatory agencies.
Economic downturns and changes in government policies affecting healthcare spending.

Key players in global Active Pharmaceutical Ingredients (API) market include:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Market segmentation, by product types:
Synthetic APIs
Biotech APIs

Market segmentation, by applications:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Table Of Contents: 

1 Industry Overview of Active Pharmaceutical Ingredients (API)
1.1 Research Scope
1.2 Market Segmentation by Types of Active Pharmaceutical Ingredients (API)
1.3 Market Segmentation by End Users of Active Pharmaceutical Ingredients (API)
1.4 Market Dynamics Analysis of Active Pharmaceutical Ingredients (API)
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces

2 Major Manufacturers Analysis of Active Pharmaceutical Ingredients (API) Industry
2.1 Teva
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Mylan
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 DSM
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Aurobindo Pharma
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Aspen
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Novartis
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 BASF
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Pfizer
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Huahai Pharmaceutical
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Hisun Pharmaceutical
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.10.4 Contact Information
2.11 Sun Pharmaceutical Industries
2.11.1 Company Overview
2.11.2 Main Products and Specifications
2.11.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.11.4 Contact Information
2.12 Zhejiang Medicine
2.12.1 Company Overview
2.12.2 Main Products and Specifications
2.12.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.12.4 Contact Information
2.13 Dr. Reddy’s Laboratories
2.13.1 Company Overview
2.13.2 Main Products and Specifications
2.13.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.13.4 Contact Information
2.14 Zhejiang NHU
2.14.1 Company Overview
2.14.2 Main Products and Specifications
2.14.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.14.4 Contact Information
2.15 Bayer
2.15.1 Company Overview
2.15.2 Main Products and Specifications
2.15.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.15.4 Contact Information
2.16 NCPC
2.16.1 Company Overview
2.16.2 Main Products and Specifications
2.16.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.16.4 Contact Information
2.17 AbbVie
2.17.1 Company Overview
2.17.2 Main Products and Specifications
2.17.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.17.4 Contact Information
2.18 Shandong Xinhua Pharmaceutical
2.18.1 Company Overview
2.18.2 Main Products and Specifications
2.18.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.18.4 Contact Information
2.19 Northeast Pharm
2.19.1 Company Overview
2.19.2 Main Products and Specifications
2.19.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.19.4 Contact Information
2.20 Harbin Pharmaceutical
2.20.1 Company Overview
2.20.2 Main Products and Specifications
2.20.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.20.4 Contact Information
2.21 LKPC
2.21.1 Company Overview
2.21.2 Main Products and Specifications
2.21.3 Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.21.4 Contact Information

3 Global Active Pharmaceutical Ingredients (API) Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Volume and Revenue of Active Pharmaceutical Ingredients (API) by Regions (2018-2023)
3.2 Global Sales Volume and Revenue of Active Pharmaceutical Ingredients (API) by Manufacturers (2018-2023)
3.3 Global Sales Volume and Revenue of Active Pharmaceutical Ingredients (API) by Types (2018-2023)
3.4 Global Sales Volume and Revenue of Active Pharmaceutical Ingredients (API) by End Users (2018-2023)
3.5 Selling Price Analysis of Active Pharmaceutical Ingredients (API) by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Active Pharmaceutical Ingredients (API) Market Analysis by Countries, Types and End Users
4.1 Northern America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Countries (2018-2023)
4.2 Northern America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Types (2018-2023)
4.3 Northern America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by End Users (2018-2023)
4.4 United States Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
4.5 Canada Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Active Pharmaceutical Ingredients (API) Market Analysis by Countries, Types and End Users
5.1 Europe Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Countries (2018-2023)
5.2 Europe Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Types (2018-2023)
5.3 Europe Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by End Users (2018-2023)
5.4 Germany Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.5 France Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.6 UK Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.7 Italy Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.8 Russia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.9 Spain Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.10 Netherlands Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Active Pharmaceutical Ingredients (API) Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by End Users (2018-2023)
6.4 China Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.5 Japan Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.6 Korea Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.7 India Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.8 Australia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.9 Indonesia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.10 Vietnam Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Active Pharmaceutical Ingredients (API) Market Analysis by Countries, Types and End Users
7.1 Latin America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Countries (2018-2023)
7.2 Latin America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Types (2018-2023)
7.3 Latin America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by End Users (2018-2023)
7.4 Brazil Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.5 Mexico Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.6 Argentina Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.7 Colombia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Analysis by End Users (2018-2023)
8.4 Turkey Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.5 Saudi Arabia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.6 South Africa Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.7 Egypt Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders

10 Global Active Pharmaceutical Ingredients (API) Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Volume and Revenue Forecast of Active Pharmaceutical Ingredients (API) by Regions (2024-2029)
10.2 Global Sales Volume and Revenue Forecast of Active Pharmaceutical Ingredients (API) by Types (2024-2029)
10.3 Global Sales Volume and Revenue Forecast of Active Pharmaceutical Ingredients (API) by End Users (2024-2029)
10.4 Global Revenue Forecast of Active Pharmaceutical Ingredients (API) by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Active Pharmaceutical Ingredients (API)
11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Active Pharmaceutical Ingredients (API)
11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Active Pharmaceutical Ingredients (API)
11.1.2 Major Equipment Suppliers with Contact Information Analysis of Active Pharmaceutical Ingredients (API)
11.2 Downstream Major Consumers Analysis of Active Pharmaceutical Ingredients (API)
11.3 Major Suppliers of Active Pharmaceutical Ingredients (API) with Contact Information
11.4 Supply Chain Relationship Analysis of Active Pharmaceutical Ingredients (API)

12 Active Pharmaceutical Ingredients (API) New Project Investment Feasibility Analysis
12.1 Active Pharmaceutical Ingredients (API) New Project SWOT Analysis
12.2 Active Pharmaceutical Ingredients (API) New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule

13 Active Pharmaceutical Ingredients (API) Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/hjresearch/global-active-pharmaceutical-ingredients-api-market-report-2018-2029

Links
[1] /countries/global[2] /specialty-chemicals[3] /manufacturing-chemicals[4] /chemicals